Response of peripheral blood mononuclear cells from lupus patients to stimulation by CpG oligodeoxynucleotides

被引:25
作者
Zeuner, RA
Klinman, DM
Illei, G
Yarboro, C
Ishii, KJ
Gursel, M
Verthelyi, D
机构
[1] US FDA, Sect Retroviral Res, Ctr Biol Evaluat & Res, Bethesda, MD 20892 USA
[2] NIAMS, NIH, Bethesda, MD USA
[3] Univ Kiel, Med Clin 2, D-24098 Kiel, Germany
关键词
SLE; innate immune system; CpG oligodeoxynucleotide; toll-like receptor; dendritic cells;
D O I
10.1093/rheumatology/keg191
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives. Increased levels of hypomethylated CpG-containing DNA in sera from patients with systemic lupus erythematosus (SLE) may contribute to the initiation and/or perpetuation of the disease. This study characterizes the in vitro response of peripheral blood mononuclear cells (PBMC) from SLE patients to CpG DNA. Methods. Secretion of cytokines and IgM, cell proliferation and up-regulation of co-stimulatory molecules were evaluated in PBMC from SLE patients (n = 24) and normal controls (n = 24) after stimulation with synthetic oligodeoxynucleotides (ODN) containing CpG motifs. Results. Up-regulation of co-stimulatory molecules and the secretion of interferon-alpha and interleukin-6 (IL-6) in response to CpG ODN was significantly reduced in monocytes and dendritic cells from SLE patients. Secretion of interferon-gamma by natural killer (NK) cells was also reduced. In contrast, the IgM and IL-10 response of B cells to CpG ODN was normal. Conclusion. Monocytes, dendritic cells and NK cells from SLE patients respond abnormally to CpG ODN stimulation, which may contribute to the cytokine imbalance observed in SLE.
引用
收藏
页码:563 / 569
页数:7
相关论文
共 31 条
[1]   Induction of dendritic cell differentiation by IFN-α in systemic lupus erythematosus [J].
Blanco, P ;
Palucka, AK ;
Gill, M ;
Pascual, V ;
Banchereau, J .
SCIENCE, 2001, 294 (5546) :1540-1543
[2]   Innate immune mechanisms in the pathogenesis of systemic lupus erythematosus (SLE) [J].
de la Fuente, H ;
Richaud-Patin, Y ;
Jakez-Ocampo, J ;
González-Amaro, R ;
Llorente, L .
IMMUNOLOGY LETTERS, 2001, 77 (03) :175-180
[3]   Immunostimulatory CpG-oligonucleotides cause proliferation, cytokine production, and an immunogenic phenotype in chronic lymphocytic leukemia B cells [J].
Decker, T ;
Schneller, F ;
Sparwasser, T ;
Tretter, T ;
Lipford, GB ;
Wagner, H ;
Peschel, C .
BLOOD, 2000, 95 (03) :999-1006
[4]   Lack of NK cells in lupus patients with renal involvement [J].
ErkellerYuksel, FM ;
Lydyard, PM ;
Isenberg, DA .
LUPUS, 1997, 6 (09) :708-712
[5]  
GILKESON GS, 1989, J IMMUNOL, V142, P1482
[6]   PHENOTYPE AND FREQUENCY OF CELLS SECRETING IL-2, IL-4, IL-6, IL-10, IFN AND TNF-ALPHA IN HUMAN PERIPHERAL-BLOOD [J].
HAGIWARA, E ;
ABBASI, F ;
MOR, G ;
ISHIGATSUBO, Y ;
KLINMAN, DM .
CYTOKINE, 1995, 7 (08) :815-822
[7]   Disease severity in patients with systemic lupus erythematosus correlates with an increased ratio of interleukin-10:Interferon-gamma-secreting cells in the peripheral blood [J].
Hagiwara, E ;
Gourley, MF ;
Lee, S ;
Klinman, DM .
ARTHRITIS AND RHEUMATISM, 1996, 39 (03) :379-385
[8]   Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus [J].
Hochberg, MC .
ARTHRITIS AND RHEUMATISM, 1997, 40 (09) :1725-1725
[9]   Quantitative expression of Toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides [J].
Hornung, V ;
Rothenfusser, S ;
Britsch, S ;
Krug, A ;
Jahrsdörfer, B ;
Giese, T ;
Endres, S ;
Hartmann, G .
JOURNAL OF IMMUNOLOGY, 2002, 168 (09) :4531-4537
[10]   Now I know my CpGs [J].
Krieg, AM .
TRENDS IN MICROBIOLOGY, 2001, 9 (06) :249-252